<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489798</url>
  </required_header>
  <id_info>
    <org_study_id>MHST2016-04</org_study_id>
    <nct_id>NCT03489798</nct_id>
  </id_info>
  <brief_title>Comparison of Two Protocols of Misoprostol (PGE1) and the Rate of Cesarean Section Due to Failed Induction.</brief_title>
  <official_title>Comparison of Two Protocols of Misoprostol (PGE1) and Their Effect on the Rate of Cesarean Section Due to Failed Induction. A Randomized, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Thomas Hospital, Panama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sistema Nacional de Investigadores de Panamá</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Saint Thomas Hospital, Panama</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare two protocols of misoprostol use for cervical ripening: 3 doses (25 ug vaginal
      each) or up to six doses, every six hours, until an adequate cervical condititon was achieved
      (BIshop score &gt; 6). In the first group, after 3 doses, the patient was sent to the delivery
      room for induction with oxytocin and in case of failure, a cesarean section was indicated for
      this reason. In the second group, up to six doses were used in a similar fashion. Rates of
      success were evaluated, as well as maternal and fetal complications.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 5, 2018</start_date>
  <completion_date type="Anticipated">June 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal birth</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients that had a vaginal birth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal complications</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients that developed a maternal complication due to the use of misoprostol (abruptio placenta, postpartum bleeding, uterine atony).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal complications</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients that developed a fetal complication due to the use of misoprostol (stillbirth, fetal distress).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Induction of Labor</condition>
  <arm_group>
    <arm_group_label>6 Misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to six doses of 25ug of misoprostol applied every 6 hours. End point is cervical Bishop score &gt; 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Up to 3 doses of 25ug of misoprostol applied every 6 hours. End point is cervical Bishop score &gt; 6.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>6 misoprostol</intervention_name>
    <description>Up to 6 doses of 25ug of misoprostol applied every 6 hours. End point is cervical Bishop score &gt; 6.</description>
    <arm_group_label>6 Misoprostol</arm_group_label>
    <other_name>Prostaglandin E1 25 ug dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3 misoprostol</intervention_name>
    <description>Up to 3 doses of 25ug of misoprostol applied every 6 hours. End point is cervical Bishop score &gt; 6.</description>
    <arm_group_label>3 misoprostol</arm_group_label>
    <other_name>Prostaglandin E1 25 ug dose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women between 34 and 42 weeks of gestation.

          -  Obstetric indication for termination of pregnancy.

          -  No fetal evidence of fetal distress

        Exclusion Criteria:

          -  Any contraindication for the use of misoprostol.

          -  Oligohydramnios.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arlenne Méndez, MD</last_name>
    <phone>5075065019</phone>
    <email>arlenne.mendez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Osvaldo Reyes, MD</last_name>
    <email>oreyesmaternidad@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Saint Thomas Maternity Hospital</name>
      <address>
        <city>Panama</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Thomas Hospital, Panama</investigator_affiliation>
    <investigator_full_name>Osvaldo A. Reyes T.</investigator_full_name>
    <investigator_title>Investigator - Head: Research Department</investigator_title>
  </responsible_party>
  <keyword>Induction of labor</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Failed induction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Alprostadil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

